Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans. C., Abarca, Katia, Rivera, Luis, Lattanzi, Maria, Pedotti, Paola, Arora, Ashwani, Kieninger-Baum, Dorothee, Della Cioppa, GiovanniVolume:
33
Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2014.10.085
Date:
January, 2015
File:
PDF, 1.08 MB
english, 2015